BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
News | 05. 21. 2013
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
